| Authors: |
Wieder-Finesod A; Infectious Diseases Unit, Sheba Medical Centre, Ramat-Gan, Israel; Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel. Electronic address: Anat.Wieder@sheba.health.gov.il., Yahav D; Infectious Diseases Unit, Sheba Medical Centre, Ramat-Gan, Israel; Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel., Rubin C; Infection Prevention & Control Unit, Sheba Medical Centre, Ramat-Gan, Israel., Hashkor S; Infection Prevention & Control Unit, Sheba Medical Centre, Ramat-Gan, Israel., Southern J; Pfizer Real World Evidence, Vaccines, Collegeville, PA, USA., Mircus G; Pfizer Vaccines, Collegeville, PA, USA., Theilacker C; Pfizer Vaccines, Collegeville, PA, USA., Dagan R; Faculty of Health Sciences, Shraga Segal Department of Microbiology, Immunology and Genetics, Ben Gurion University, Beer Sheva, Israel., Regev-Yochay G; Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel; Infection Prevention & Control Unit, Sheba Medical Centre, Ramat-Gan, Israel; The Sheba Pandemic Preparedness Research Institute (SPRI), Sheba Medical Centre, Ramat Gan, Israel. |